Amy Nagelberg

Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance <i>EGFR</i> Mutations

Jacqueline H. Starrett, Alexis Guernet, Maria Emanuela Cuomo et al. · Cancer Research · 2020 · 57 citations · Full text

Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4

Jack Calder, Amy Nagelberg, Jennifer Luu et al. · Oncogenesis · 2021 · 26 citations · Full text

Characterization of a small molecule inhibitor of disulfide reductases that induces oxidative stress and lethality in lung cancer cells

Fraser Johnson, John R. Ferrarone, Alvin Liu et al. · Cell Reports · 2022 · 26 citations · Full text

Molecular Biology, Small Molecule Inhibitor, Disulfide Reductase Activity +19

Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung Tumorigenesis

Hannah E. O’Farrell, Bryant Harbourne, Zimple Kurlawala et al. · Journal of Thoracic Oncology · 2018 · 22 citations

Egfr-mediated Lung Tumorigenesis, Cooperative Driver, Medicine +8

MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis

Daniel Lu, Amy Nagelberg, Justine LM. Chow et al. · Cancers · 2022 · 11 citations · Full text